RNXT Tin tức Forex

Biopharmaceutical company RenovoRx, Inc. (RNXT) announced Tuesday the appointment of James Ahlers as Chief Financial Officer (CFO), effective July 15, 2022. Ahlers replaces Christopher Lehman, who joined RenovoRx in connection with its initial public offering and is leaving to pursue a new business opportunity.